Records containing: Sodium-Glucose Transporter 2 Inhibitors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-27SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Double-blind, Placebo Controlled, National, Multicenter Trial
-
CLINICAL_TRIALS study record update · 2025-07-31Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension: A Randomized, Double-blind, Placebo Controlled Crossover Trial
-
CLINICAL_TRIALS study record update · 2024-05-09Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Advanced Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2023-09-07Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome
-
CLINICAL_TRIALS study record update · 2023-08-02Management of Diuretic Refractory Ascites in Cirrhosis With Empagliflozin (DRAin-Em-01)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-08-02Sodium-Glucose CoTransporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production